Molecular Diagnostics Market is projected to exceed US$ 20 Billion by 2024

by Renub Research Renub Research is a Market Research and Consulting

Molecular diagnostics is termed as to the detection of genomic variants, with the aim to facilitate physicians in the detection, prognosis, diagnosis, sub-classification and further monitoring response to the given therapy. Molecular diagnostics is the outcome of productive relationships between genomics knowledge, laboratory medicine and the use of improved technology in the field of molecular genetics. All these factors help in the better recognition and fine categorization of the genetic basis of inherited diseases which in turn, is essential for the accurate specification of disease diagnosis. Global Molecular Diagnostics Market is projected to exceed US$ 20 Billion by the year 2024.

Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS)

Over the last few decades, several molecular assays have been developed using a variety of technologies. Molecular diagnostics by using Polymerase Chain Reaction (PCR) is one of the leading molecular diagnostics technologies, which is being used for the rapid diagnosis of various diseases. For instance: diagnosis of pulmonary tuberculosis using Polymerase Chain Reaction (PCR) is demonstrating a high yield even in patients with sputum smear-negative pulmonary tuberculosis and is now being endorsed for routine use by WHO. High-end molecular diagnostic techniques such as next-generation sequencing (NGS) offer valuable insights into the mechanisms of disease while genomic biomarkers provide physician not only to evaluate the disease predilection but also to implement accurate diagnostic techniques and to individualize medicinal modalities.  


Molecular Diagnostics for Infectious Disease

Over the last several years, the expansion and application of molecular diagnostic techniques has spurred a revolution in the field of disease diagnosis and monitoring, especially for infectious diseases. Microbial phenotypic characteristics, such as bacteriophage, protein and chromatographic profiles, as well as susceptibility testing and biotyping, are used wide openly in today’s everyday laboratories for identification and differentiation. Nucleic acid techniques, such as various methods for generating restriction fragment length polymorphisms, plasmid profiling, and the polymerase chain reaction (PCR), are making increasing incursion into clinical laboratories. A PCR-based system helps to detect the etiology of the disease straight from the clinical samples without the need for culture and have been significantly useful in the rapid detection of un-culturable or fastidious microbes. In addition; sequence analysis of amplified microbial DNA allows for better characterization and identification of the pathogen.


Click here for Diagnostics Market Research Reports:


Further, molecular diagnostics have also paved the roads for the microbiologists who now searched for go for more rapid and efficient means of microbial identification. The identification and differentiation of microbes have basically relied on the microbial growth variables and their morphology. Advancement in the molecular diagnostics has opened new possibilities for microbial identification and characterization.


Molecular Diagnostics Market is exploding very rapidly in the past few years as it has proven readily versatile for use in the clinical laboratory and promise to be exceptionally useful in the diagnosis, therapy, and epidemiologic investigations of various diseases and their control; it is believed that the molecular diagnostics market will keep flourishing in the coming years. Also, rapid detection and tests accuracy are believed to drive demand for molecular diagnostic tests for infectious disease. 

Sponsor Ads

About Renub Research Freshman   Renub Research is a Market Research and Consulting

7 connections, 0 recommendations, 22 honor points.
Joined APSense since, January 12th, 2019, From Roswell, United States.

Created on Feb 11th 2019 23:35. Viewed 280 times.


No comment, be the first to comment.
Please sign in before you comment.